2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one

C22H26N10O13P2 — CID 155053142

IUPAC2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one
SMILESNc1nc2c(ncn2C2OC3COP(=O)(O)OC4C(COP(=O)(O)OC2C3O)OC(N2CNc3c2ncn2ccnc32)C4O)c(=O)[nH]1
InChIInChI=1S/C22H26N10O13P2/c23-22-28-18-11(19(35)29-22)26-7-32(18)21-15-12(33)8(42-21)3-40-46(36,37)44-14-9(4-41-47(38,39)45-15)43-20(13(14)34)31-6-25-10-16-24-1-2-30(16)5-27-17(10)31/h1-2,5,7-9,12-15,20-21,25,33-34H,3-4,6H2,(H,36,37)(H,38,39)(H3,23,28,29,35)
InChIKeyAZNDCKLWXSMNLK-UHFFFAOYSA-N
MW700.45 g/mol
LogP-2.00
Rot. Bonds2

About 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one

2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one (PubChem CID 155053142) has the molecular formula C22H26N10O13P2 and a molecular weight of 700.45 g/mol. Its IUPAC name is 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one.

Molecular Properties

Compound Name2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one
PubChem CID155053142
Molecular FormulaC22H26N10O13P2
Molecular Weight700.45 g/mol
Exact Mass700.12
IUPAC Name2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one
SMILESNc1nc2c(ncn2C2OC3COP(=O)(O)OC4C(COP(=O)(O)OC2C3O)OC(N2CNc3c2ncn2ccnc32)C4O)c(=O)[nH]1
InChIInChI=1S/C22H26N10O13P2/c23-22-28-18-11(19(35)29-22)26-7-32(18)21-15-12(33)8(42-21)3-40-46(36,37)44-14-9(4-41-47(38,39)45-15)43-20(13(14)34)31-6-25-10-16-24-1-2-30(16)5-27-17(10)31/h1-2,5,7-9,12-15,20-21,25,33-34H,3-4,6H2,(H,36,37)(H,38,39)(H3,23,28,29,35)
InChIKeyAZNDCKLWXSMNLK-UHFFFAOYSA-N
XLogP-2.00
TPSA305.49 Ų
H-Bond Donors7
H-Bond Acceptors20
Rotatable Bonds2
Heavy Atoms47
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500700.45
LogP ≤ 5-2.00
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one?
The IUPAC name of 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one (CID 155053142) is 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one.
What is the SMILES notation for 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one?
The canonical SMILES for 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one is Nc1nc2c(ncn2C2OC3COP(=O)(O)OC4C(COP(=O)(O)OC2C3O)OC(N2CNc3c2ncn2ccnc32)C4O)c(=O)[nH]1.
What is the InChIKey of 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one?
The InChIKey is AZNDCKLWXSMNLK-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H26N10O13P2/c23-22-28-18-11(19(35)29-22)26-7-32(18)21-15-12(33)8(42-21)3-40-46(36,37)44-14-9(4-41-47(38,39)45-15)43-20(13(14)34)31-6-25-10-16-24-1-2-30(16)5-27-17(10)31/h1-2,5,7-9,12-15,20-21,25,33-34H,3-4,6H2,(H,36,37)(H,38,39)(H3,23,28,29,35).
What are the key properties of 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one?
2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one has a molecular weight of 700.45 g/mol, XLogP of -2.00, 2 rotatable bonds, 7 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-9-[8-(1,2-dihydroimidazo[2,1-f]purin-3-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-2,4,7,11,13,16-hexaoxa-3λ5,12λ5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one is sourced from PubChem (CID 155053142), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).